Nutrition & Diabetes最新文献

筛选
英文 中文
The role of peripheral white blood cell counts in the association between central adiposity and glycemic status 外周白细胞计数在中心脂肪含量与血糖状况之间的关联中的作用
IF 6.1 2区 医学
Nutrition & Diabetes Pub Date : 2024-05-17 DOI: 10.1038/s41387-024-00271-9
Feng-qiong Liu, Yanni Li, Wanxin Li, Ruimei Feng, Hongwei Zhao, Jun Chen, Shanshan Du, Weimin Ye
{"title":"The role of peripheral white blood cell counts in the association between central adiposity and glycemic status","authors":"Feng-qiong Liu, Yanni Li, Wanxin Li, Ruimei Feng, Hongwei Zhao, Jun Chen, Shanshan Du, Weimin Ye","doi":"10.1038/s41387-024-00271-9","DOIUrl":"https://doi.org/10.1038/s41387-024-00271-9","url":null,"abstract":"","PeriodicalId":19339,"journal":{"name":"Nutrition & Diabetes","volume":null,"pages":null},"PeriodicalIF":6.1,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140963672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of peripheral white blood cell counts in the association between central adiposity and glycemic status. 外周白细胞计数在中心脂肪含量与血糖状况之间的关联中的作用。
IF 4.6 2区 医学
Nutrition & Diabetes Pub Date : 2024-05-17 DOI: 10.1038/s41387-024-00271-9
Fengqiong Liu, Yanni Li, Wanxin Li, Ruimei Feng, Hongwei Zhao, Jun Chen, Shanshan Du, Weimin Ye
{"title":"The role of peripheral white blood cell counts in the association between central adiposity and glycemic status.","authors":"Fengqiong Liu, Yanni Li, Wanxin Li, Ruimei Feng, Hongwei Zhao, Jun Chen, Shanshan Du, Weimin Ye","doi":"10.1038/s41387-024-00271-9","DOIUrl":"10.1038/s41387-024-00271-9","url":null,"abstract":"<p><strong>Aims: </strong>Although central adiposity is a well-known risk factor for diabetes, the underlying mechanism remains unclear. The aim of this study was to explore the potential mediation role of circulating WBC counts in the association between central adiposity and the risk of diabetes.</p><p><strong>Materials and methods: </strong>A cross-sectional study was conducted using data from the Fuqing cohort study, which included 6,613 participants aged 35-75 years. Logistic regression analysis and Spearman's rank correlation analysis were used to examine the relationships between waist-to-hip ratio, WBC counts and glycemic status. Both simple and parallel multiple mediation models were used to explore the potential mediation effects of WBCs on the association of waist-to-hip ratio with diabetes.</p><p><strong>Results: </strong>The study revealed a positive relationship between waist-to-hip ratio and risk of prediabetes (OR = 1.53; 95% CI, 1.35 to 1.74) and diabetes (OR = 2.89; 95% CI, 2.45 to 3.40). Moreover, elevated peripheral WBC counts were associated with both central adiposity and worsening glycemic status (P < 0.05). The mediation analysis with single mediators demonstrated that there is a significant indirect effect of central adiposity on prediabetes risk through total WBC count, neutrophil count, lymphocyte count, and monocyte count; the proportions mediated were 9.92%, 6.98%, 6.07%, and 3.84%, respectively. Additionally, total WBC count, neutrophil count, lymphocyte count, monocyte count and basophil count mediated 11.79%, 11.51%, 6.29%, 4.78%, and 1.76%, respectively, of the association between central adiposity and diabetes. In the parallel multiple mediation model using all five types of WBC as mediators simultaneously, a significant indirect effect (OR = 1.09; 95% CI, 1.06 to 1.14) were observed, with a mediated proportion of 12.77%.</p><p><strong>Conclusions: </strong>Central adiposity was independently associated with an elevated risk of diabetes in a Chinese adult population; levels of circulating WBC may contribute to its underlying mechanisms.</p>","PeriodicalId":19339,"journal":{"name":"Nutrition & Diabetes","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11101409/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140958649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Taurine reduces the risk for metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials 牛磺酸降低代谢综合征风险:随机对照试验的系统回顾和荟萃分析
IF 6.1 2区 医学
Nutrition & Diabetes Pub Date : 2024-05-16 DOI: 10.1038/s41387-024-00289-z
Chih-Chen Tzang, Liang-Yun Chi, Long-Huei Lin, Ting-Yu Lin, K. Chang, Wei-Ting Wu, Levent Özçakar
{"title":"Taurine reduces the risk for metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials","authors":"Chih-Chen Tzang, Liang-Yun Chi, Long-Huei Lin, Ting-Yu Lin, K. Chang, Wei-Ting Wu, Levent Özçakar","doi":"10.1038/s41387-024-00289-z","DOIUrl":"https://doi.org/10.1038/s41387-024-00289-z","url":null,"abstract":"","PeriodicalId":19339,"journal":{"name":"Nutrition & Diabetes","volume":null,"pages":null},"PeriodicalIF":6.1,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140971292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Common food additive carrageenan inhibits proglucagon expression and GLP-1 secretion by human enteroendocrine L-cells 常见食品添加剂卡拉胶抑制人肠内分泌 L 细胞的胰高血糖素表达和 GLP-1 分泌
IF 6.1 2区 医学
Nutrition & Diabetes Pub Date : 2024-05-16 DOI: 10.1038/s41387-024-00284-4
S. Bhattacharyya, A. Borthakur, J. Tobacman
{"title":"Common food additive carrageenan inhibits proglucagon expression and GLP-1 secretion by human enteroendocrine L-cells","authors":"S. Bhattacharyya, A. Borthakur, J. Tobacman","doi":"10.1038/s41387-024-00284-4","DOIUrl":"https://doi.org/10.1038/s41387-024-00284-4","url":null,"abstract":"","PeriodicalId":19339,"journal":{"name":"Nutrition & Diabetes","volume":null,"pages":null},"PeriodicalIF":6.1,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140970275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Common food additive carrageenan inhibits proglucagon expression and GLP-1 secretion by human enteroendocrine L-cells. 常见食品添加剂卡拉胶可抑制人肠内分泌 L 细胞的胰高血糖素表达和 GLP-1 分泌。
IF 4.6 2区 医学
Nutrition & Diabetes Pub Date : 2024-05-16 DOI: 10.1038/s41387-024-00284-4
Sumit Bhattacharyya, Alip Borthakur, Joanne K Tobacman
{"title":"Common food additive carrageenan inhibits proglucagon expression and GLP-1 secretion by human enteroendocrine L-cells.","authors":"Sumit Bhattacharyya, Alip Borthakur, Joanne K Tobacman","doi":"10.1038/s41387-024-00284-4","DOIUrl":"10.1038/s41387-024-00284-4","url":null,"abstract":"<p><p>Proglucagon mRNA expression and GLP-1 secretion by cultured human L-cells (NCI-H716) were inhibited following exposure to λ-carrageenan, a commonly used additive in processed foods. Carrageenan is composed of sulfated or unsulfated galactose residues linked in alternating alpha-1,3 and beta-1,4 bonds and resembles the endogenous sulfated glycosaminoglycans. However, carrageenan has unusual alpha-1,3-galactosidic bonds, which are not innate to human cells and are implicated in immune responses. Exposure to carrageenan predictably causes inflammation, and carrageenan impairs glucose tolerance and contributes to insulin resistance. When cultured human L-cells were deprived overnight of glucose and serum and then exposed to high glucose, 10% FBS, and λ-carrageenan (1 µg/ml) for 10 minutes, 1 h, and 24 h, mRNA expression of proglucagon and secretion of GLP-1 were significantly reduced, compared to control cells not exposed to carrageenan. mRNA expression of proglucagon by mouse L-cells (STC-1) was also significantly reduced and supports the findings in the human cells. Exposure of co-cultured human intestinal epithelial cells (LS174T) to the spent media of the carrageenan-treated L-cells led to a decline in mRNA expression of GLUT-2 at 24 h. These findings suggest that ingestion of carrageenan-containing processed foods may impair the production of GLP-1, counteract the effect of GLP-1 receptor agonists and induce secondary effects on intestinal epithelial cells.</p>","PeriodicalId":19339,"journal":{"name":"Nutrition & Diabetes","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11099076/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140961477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Taurine reduces the risk for metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials. 牛磺酸降低代谢综合征风险:随机对照试验的系统回顾和荟萃分析。
IF 4.6 2区 医学
Nutrition & Diabetes Pub Date : 2024-05-16 DOI: 10.1038/s41387-024-00289-z
Chih-Chen Tzang, Liang-Yun Chi, Long-Huei Lin, Ting-Yu Lin, Ke-Vin Chang, Wei-Ting Wu, Levent Özçakar
{"title":"Taurine reduces the risk for metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials.","authors":"Chih-Chen Tzang, Liang-Yun Chi, Long-Huei Lin, Ting-Yu Lin, Ke-Vin Chang, Wei-Ting Wu, Levent Özçakar","doi":"10.1038/s41387-024-00289-z","DOIUrl":"10.1038/s41387-024-00289-z","url":null,"abstract":"<p><strong>Background: </strong>Metabolic syndrome (MetS) is a cluster of interconnected risk factors that significantly increase the likelihood of cardiovascular disease and type 2 diabetes. Taurine has emerged as a potential therapeutic agent for MetS. This meta-analysis of randomized controlled trials (RCTs) aimed to evaluate the effects of taurine supplementation on MetS-related parameters.</p><p><strong>Methods: </strong>We conducted electronic searches through databases like Embase, PubMed, Web of Science, Cochrane CENTRAL, and ClinicalTrials.gov, encompassing publications up to December 1, 2023. Our analysis focused on established MetS diagnostic criteria, including systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting blood glucose (FBG), triglyceride (TG), and high-density lipoprotein cholesterol (HDL-C). Meta-regression explored potential dose-dependent relationships based on the total taurine dose administered during the treatment period. We also assessed secondary outcomes like body composition, lipid profile, and glycemic control.</p><p><strong>Results: </strong>Our analysis included 1024 participants from 25 RCTs. The daily dosage of taurine in the studies ranged from 0.5 g/day to 6 g/day, with follow-up periods varying between 5 and 365 days. Compared to control groups, taurine supplementation demonstrated statistically significant reductions in SBP (weighted mean difference [WMD] = -3.999 mmHg, 95% confidence interval [CI] = -7.293 to -0.706, p = 0.017), DBP (WMD = -1.509 mmHg, 95% CI = -2.479 to -0.539, p = 0.002), FBG (WMD: -5.882 mg/dL, 95% CI: -10.747 to -1.018, p = 0.018), TG (WMD: -18.315 mg/dL, 95% CI: -25.628 to -11.002, p < 0.001), but not in HDL-C (WMD: 0.644 mg/dl, 95% CI: -0.244 to 1.532, p = 0.155). Meta-regression analysis revealed a dose-dependent reduction in DBP (coefficient = -0.0108 mmHg per g, p = 0.0297) and FBG (coefficient = -0.0445 mg/dL per g, p = 0.0273). No significant adverse effects were observed compared to the control group.</p><p><strong>Conclusion: </strong>Taurine supplementation exhibits positive effects on multiple MetS-related factors, making it a potential dietary addition for individuals at risk of or already experiencing MetS. Future research may explore dose-optimization strategies and potential long-term benefits of taurine for MetS management.</p>","PeriodicalId":19339,"journal":{"name":"Nutrition & Diabetes","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11099170/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140958648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mediterranean diet as a strategy for preserving kidney function in patients with coronary heart disease with type 2 diabetes and obesity: a secondary analysis of CORDIOPREV randomized controlled trial 地中海饮食作为保护冠心病合并 2 型糖尿病和肥胖症患者肾功能的策略:CORDIOPREV 随机对照试验的二次分析
IF 6.1 2区 医学
Nutrition & Diabetes Pub Date : 2024-05-16 DOI: 10.1038/s41387-024-00285-3
Alicia Podadera-Herreros, Antonio P. Arenas-de Larriva, F. Gutierrez-Mariscal, J. Alcalá-Díaz, Ana Ojeda-Rodriguez, F. Rodríguez-Cantalejo, M. Cardelo, Diego Rodríguez-Cano, J. Torres-Peña, Raúl M. Luque, J. Ordovás, P. Pérez-Martínez, J. Delgado-Lista, J. López-Miranda, E. Yubero-Serrano
{"title":"Mediterranean diet as a strategy for preserving kidney function in patients with coronary heart disease with type 2 diabetes and obesity: a secondary analysis of CORDIOPREV randomized controlled trial","authors":"Alicia Podadera-Herreros, Antonio P. Arenas-de Larriva, F. Gutierrez-Mariscal, J. Alcalá-Díaz, Ana Ojeda-Rodriguez, F. Rodríguez-Cantalejo, M. Cardelo, Diego Rodríguez-Cano, J. Torres-Peña, Raúl M. Luque, J. Ordovás, P. Pérez-Martínez, J. Delgado-Lista, J. López-Miranda, E. Yubero-Serrano","doi":"10.1038/s41387-024-00285-3","DOIUrl":"https://doi.org/10.1038/s41387-024-00285-3","url":null,"abstract":"","PeriodicalId":19339,"journal":{"name":"Nutrition & Diabetes","volume":null,"pages":null},"PeriodicalIF":6.1,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140969839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mediterranean diet as a strategy for preserving kidney function in patients with coronary heart disease with type 2 diabetes and obesity: a secondary analysis of CORDIOPREV randomized controlled trial. 地中海饮食作为保护冠心病合并 2 型糖尿病和肥胖症患者肾功能的策略:CORDIOPREV 随机对照试验的二次分析。
IF 4.6 2区 医学
Nutrition & Diabetes Pub Date : 2024-05-16 DOI: 10.1038/s41387-024-00285-3
Alicia Podadera-Herreros, Antonio P Arenas-de Larriva, Francisco M Gutierrez-Mariscal, Juan F Alcala-Diaz, Ana Ojeda-Rodriguez, Fernando Rodriguez-Cantalejo, Magdalena P Cardelo, Diego Rodriguez-Cano, Jose D Torres-Peña, Raul M Luque, Jose M Ordovas, Pablo Perez-Martinez, Javier Delgado-Lista, Jose Lopez-Miranda, Elena M Yubero-Serrano
{"title":"Mediterranean diet as a strategy for preserving kidney function in patients with coronary heart disease with type 2 diabetes and obesity: a secondary analysis of CORDIOPREV randomized controlled trial.","authors":"Alicia Podadera-Herreros, Antonio P Arenas-de Larriva, Francisco M Gutierrez-Mariscal, Juan F Alcala-Diaz, Ana Ojeda-Rodriguez, Fernando Rodriguez-Cantalejo, Magdalena P Cardelo, Diego Rodriguez-Cano, Jose D Torres-Peña, Raul M Luque, Jose M Ordovas, Pablo Perez-Martinez, Javier Delgado-Lista, Jose Lopez-Miranda, Elena M Yubero-Serrano","doi":"10.1038/s41387-024-00285-3","DOIUrl":"10.1038/s41387-024-00285-3","url":null,"abstract":"<p><strong>Background: </strong>Type 2 diabetes mellitus (T2DM) is recognized an independent risk factor for chronic kidney disease (CKD). The precise contribution and differential response to treatment strategies to reduce kidney dysfunction, depending on whether obesity is present alongside T2DM or not, remain to be fully clarified. Our objective was to improve our understanding of how obesity contributes to kidney function in patients with T2DM and coronary heart disease (CHD), who are highly predisposed to CKD, to assign the most effective dietary approach to preserve kidney function.</p><p><strong>Methods: </strong>1002 patients with CHD and estimated glomerular filtration rate (eGFR)≥30 ml/min/1.73m<sup>2</sup>, were randomized to consume a Mediterranean diet (35% fat, 22% MUFA, < 50% carbohydrates) or a low-fat diet (28% fat, 12% MUFA, > 55% carbohydrates). Patients were classified into four groups according to the presence of T2DM and/or obesity at baseline: Non-Obesity/Non-T2DM, Obesity/Non-T2DM, Non-Obesity/T2DM and Obesity/T2DM. We evaluated kidney function using serum creatinine-based estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (uACR) before and after 5-years of dietary intervention.</p><p><strong>Results: </strong>Patients with Obesity/T2DM had the lowest baseline eGFR and the highest baseline uACR compared to non-diabetics (p < 0.05). After dietary intervention, the Mediterranean diet induced a lower eGFR decline in patients with Obesity/T2DM, compared to a low-fat diet but not in the other groups (p = 0.014). The Mediterranean diet, but not the low-fat diet, also reduced uACR only in patients with Obesity/T2DM (p = 0.024).</p><p><strong>Conclusions: </strong>Obesity provided an additive effect to T2DM resulting in a more pronounced decline in kidney function compared to T2DM alone when compared to non-diabetics. In patients with concomitant presence of T2DM and obesity, with more metabolic complications, consumption of a Mediterranean diet seemed more beneficial than a low-fat diet in terms of preserving kidney function. These findings provide valuable insights for tailoring personalized lifestyle modifications in secondary prevention of cardiovascular disease.</p><p><strong>Trial registration: </strong>URL, http://www.cordioprev.es/index.php/en .</p><p><strong>Clinicaltrials: </strong>gov number, NCT00924937.</p>","PeriodicalId":19339,"journal":{"name":"Nutrition & Diabetes","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11099022/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140958646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for malnutrition in patients with diabetic foot ulcer and its association with prolonged length of hospitalization 糖尿病足溃疡患者营养不良的风险因素及其与住院时间延长的关系
IF 6.1 2区 医学
Nutrition & Diabetes Pub Date : 2024-05-16 DOI: 10.1038/s41387-024-00290-6
Qian Ran, Weiwei Xu, Xili Zhao, Hang Sun, Li Liu, Yunqiu Luo
{"title":"Risk factors for malnutrition in patients with diabetic foot ulcer and its association with prolonged length of hospitalization","authors":"Qian Ran, Weiwei Xu, Xili Zhao, Hang Sun, Li Liu, Yunqiu Luo","doi":"10.1038/s41387-024-00290-6","DOIUrl":"https://doi.org/10.1038/s41387-024-00290-6","url":null,"abstract":"","PeriodicalId":19339,"journal":{"name":"Nutrition & Diabetes","volume":null,"pages":null},"PeriodicalIF":6.1,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140971107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for malnutrition in patients with diabetic foot ulcer and its association with prolonged length of hospitalization. 糖尿病足溃疡患者营养不良的风险因素及其与住院时间延长的关系。
IF 4.6 2区 医学
Nutrition & Diabetes Pub Date : 2024-05-16 DOI: 10.1038/s41387-024-00290-6
Qian Ran, Weiwei Xu, Xili Zhao, Hang Sun, Li Liu, Yunqiu Luo
{"title":"Risk factors for malnutrition in patients with diabetic foot ulcer and its association with prolonged length of hospitalization.","authors":"Qian Ran, Weiwei Xu, Xili Zhao, Hang Sun, Li Liu, Yunqiu Luo","doi":"10.1038/s41387-024-00290-6","DOIUrl":"10.1038/s41387-024-00290-6","url":null,"abstract":"<p><strong>Purpose: </strong>The study was designed to investigate the occurrence and risk factors of malnutrition in diabetic foot ulcers (DFU) patients and examine the association between malnutrition and length of stay (LOS).</p><p><strong>Methods: </strong>This observational study included DFU hospitalized patients in two campuses of a hospital from January 2021 to June 2023. The diagnosis standard of malnutrition was established by using the Global Leadership Initiative on Malnutrition (GLIM) criteria. Patients were followed up to ascertain the length of hospitalization, and hospital stays longer than 17 days were considered as prolonged LOS. To explore the risk factors of malnutrition and the association between malnutrition and LOS, univariate and multivariate logistic regression analyses were performed.</p><p><strong>Results: </strong>Overall 219 DFU patients were enrolled, malnutrition was identified in 38.36% of patients according to GLIM criteria, and 92 patients (42%) were recognized as prolonged LOS. Logistic regression analyses showed that BMI (P <0.001), Alb (P = 0.002), HbA1c (P <0.001), ulcer infection (P <0.001), LOS (P = 0.010), and ABI (P = 0.024) were independent risk factors for malnutrition. Besides, malnutrition by GLIM criteria was closely related to prolonged LOS and malnourished DFU patients were 2.857 times (95% CI, 1.497-5.450; P = 0.001) likely to present prolonged LOS than that of normal nutrition.</p><p><strong>Conclusion: </strong>Malnutrition was considered to be extremely prevalent in DFU patients and was associated with approximately three times higher likelihood of prolonged LOS. Implementing and disseminating the diagnostic criteria during routine practice is crucial, given the predictive efficacy of GLIM criteria.</p>","PeriodicalId":19339,"journal":{"name":"Nutrition & Diabetes","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11099008/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140958647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信